To Get Help Now
Click Here
Today's Date:

Bard Avaulta Mesh Bellwether Trials Expected to Begin Soon

AddThis Social Bookmark Button

Over 250 federally filed Bard Avaulta vaginal mesh lawsuits have been consolidated before Judge Goodwin in the U.S. District Court for the Southern District of West Virginia as part of multidistrict litigation. Judge Goodwin has asked the counsel for the plaintiffs and defense to each develop a list of eight potential bellwether cases to be considered for early discovery.

The lawsuits involve similar complaints that the trans-vaginal mesh used to treat pelvic organ prolapse (POP) and female stress urinary incontinence (SUI) cause serious complications including infection, painful intercourse, erosion of the mesh into the vagina, disfigurement, and urinary problems.

Last year, the FDA issued a warning about the use of surgical mesh as a treatment for POP and SUI and an increasing number of adverse event reports. Later, the federal agency issued notice that they were unable to find any evidence that the trans-vaginal mesh provided any benefit over other treatments for POP and SUI.

In early January, the FDA issued a request to makers of trans-vaginal mesh kits calling for post-marketing studies into the rate of complications reported.

On January 26, the U.S. Panel on Multidistrict Litigation will weigh arguments regarding the centralization of three other MDLs to Judge Goodwin’s court. Other manufacturers being targeted by federally filed lawsuits include Boston Scientific, Ethicon/Gynecare, and American Medical Systems over their respective trans-vaginal mesh kits. disclaimer: This article: Bard Avaulta Mesh Bellwether Trials Expected to Begin Soon was posted on Thursday, January 19th, 2012 at 9:22 pm at and is filed under Medical Device Lawsuits.

« »

Comments are closed.